(OMI) Owens & Minor - Ratings and Ratios

Owens & Minor Inc (NYSE:OMI) is a healthcare solutions company that operates globally, providing a range of products and services to healthcare providers, manufacturers, and patients. The companys two business segments, Products & Healthcare Services and Patient Direct, cater to different aspects of the healthcare industry. While Products & Healthcare Services focuses on supplying medical and surgical supplies, as well as offering services like supplier management and inventory management to healthcare providers, Patient Direct specializes in delivering products and services for in-home care, including diabetes treatment, home respiratory therapy, and obstructive sleep apnea treatment.

With a history dating back to 1882, Owens & Minor has established itself as a significant player in the healthcare distribution sector. The companys extensive portfolio includes both branded and proprietary products, as well as a range of services designed to support healthcare providers and manufacturers. By serving multi-facility networks, independent hospitals, surgery centers, and physicians practices, Owens & Minor has built a diverse customer base. The companys business model is designed to provide outsourced logistics and marketing solutions to its suppliers, while also catering to the needs of patients through its Patient Direct segment.

From a technical analysis perspective, Owens & Minors stock has been trending downwards, with its 50-day and 200-day simple moving averages (SMA) at 8.25 and 12.29, respectively, indicating a bearish sentiment. The stocks last price is 7.76, with an average true range (ATR) of 0.55, representing a 7.13% volatility. Given the current technical indicators, it is likely that the stock will continue to face downward pressure in the short term.

Fundamentally, Owens & Minors market capitalization stands at 538.46M USD, with a forward price-to-earnings ratio of 3.71. However, the companys return on equity (RoE) is -45.40, indicating significant losses. Considering the current fundamental data and technical indicators, a forecast for Owens & Minors stock price suggests that it may continue to experience volatility in the short term. If the companys RoE improves and the overall healthcare distribution sector experiences a rebound, the stock price may potentially recover. However, based on the current SMA20, SMA50, and SMA200 values, a potential target price could be around 8.50 in the short term, with a possible downside risk to 6.50 if the bearish trend continues.

To make an informed investment decision, it is essential to closely monitor Owens & Minors future earnings reports, as well as developments in the healthcare distribution sector. A thorough analysis of the companys financials, management team, and industry trends will be crucial in determining its potential for long-term growth.